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Background: Abnormalities of functional activation and cortical volume in brain regions involved in the neu-
robiology of fear and anxiety have been implicated in the pathophysiology of social anxiety disorder (SAD).
However, few studies have performed separate measurements of cortical thickness (CT) and cortical surface
area (CSA) which reflect different neurobiological processes. Thus, we aimed to explore the cortical morpho-
logical anomaly separately in SAD using FreeSurfer.
Methods: High-resolution structural magnetic resonance images were obtained from 32 non-comorbid
never-treated adult SAD patients and 32 demography-matched healthy controls. Cortical morphometry indi-
ces including CT and CSA were separately determined by FreeSurfer and compared between the two groups
via whole-brain vertex-wise analysis, while partial correlation analysis using age and gender as covariates
were conducted.
Findings: The patients with SAD showed decreased CT but increased CSA near-symmetrically in the bilateral
prefrontal cortex (PFC) of the dorsolateral, dorsomedial, and ventromedial subdivisions, as well as the right
lateral orbitofrontal cortex; increased CSA in the left superior temporal gyrus (STG) was also observed in
SAD. The CSA in the left PFC was negatively correlated with the disease duration.
Interpretation: As the balloon model hypothesis suggests that the tangentially stretched cortex may cause
dissociations in cortical morphometry and affect the cortical capacity for information processing, our findings
of dissociated morphological alterations in the PFC and cortical expansion in the STG may reflect the morpho-
logical alterations of the functional reorganization in those regions, and highlight the important role of those
structures in the pathophysiology and neurobiology of SAD.
Funding: This study was funded by the National Natural Science Foundation of China (Grant Nos. 31700964,
31800963, 81621003, and 81820108018).








V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Social anxiety disorder (SAD), also called social phobia, is a com-
mon disabling psychiatric condition characterized by marked, persis-
tent fear and emotional discomfort in social or performancesituations [1,2]. People with SAD are intensely worried about nega-
tive evaluation and scrutiny by others and attempt to avoid participa-
tion in social activities, thus causing severe personal, professional,
and academic functional impairments [3]. An estimated 7%13.3% of
people suffer from SAD at some point [4], and approximately 90% of
SAD patients have at least one comorbid disorder, such as major
depression disorder (MDD), bipolar disorder, or autism [5]. Consider-
ing the high prevalence and potential severity of SAD, understanding
this disorder better is essential for achieving early diagnosis and
timely intervention. Increasing attention is paid to understanding its
Research in Context
Evidence before this study
Social anxiety disorder (SAD) is a prevalent disabling psychiat-
ric condition characterized by marked, persistent fear and emo-
tional discomfort in social situations, accompanied with severe
personal, professional and academic functional impairments.
Increasing attention is paid to understanding its pathophysiol-
ogy and identifying potential neuroanatomical biomarkers, but
results are of limited consistency, in need of validation and rep-
lication. To date, most structural analyses have focused on cor-
tical gray matter volume using voxel-based morphometry,
revealing a widespread but variable pattern of gray matter defi-
cits. Considering the cortical volume confounds the effects of
both cortical thickness (CT) and cortical surface area (CSA),
which reflect unique characteristics in terms of brain develop-
ment, cytology, and genetics, joint analysis of CT and CSA may
offer sensitive information and better insights. However, few
studies have conducted separate investigations of CT and CSA
in SAD. Further, some researches have investigated CT altera-
tions in SAD with mixed and partially contradictory findings.
These diverse results may be attributed to some confounding
factors such as comorbidity with other psychiatric disorders,
concomitant therapy, sex ratio (e.g. studying all-male partici-
pants), and methodological differences (e.g. whole-brain vs
region-of-interest analyses). In the context, the present study
aimed to explore the cortical anomaly of CT and CSA in non-
comorbid never-treated adult patients with SAD using surface-
based morphometry (SBM) analysis.
Added value of this study
The current study showed that SAD patients had a thinner but
expanded cortex near-symmetrically in the bilateral prefrontal
cortex (PFC) of the dorsolateral, dorsomedial, and ventromedial
subdivisions, as well as the right lateral orbitofrontal cortex, in
addition to surface expansion in the left superior temporal
gyrus (STG). For the first time, our study demonstrated dissocia-
tions in CT and CSA in non-comorbid never-treated adult
patients with SAD, which might provide some useful informa-
tion for understanding the neurobiology of SAD and furtherly
characterizing candidate biomarkers in the early diagnosis and
targeted therapy.
Implications of all the available evidence
These results are consistent with the ‘balloon model’ hypothe-
sis that the tangentially stretched cortex causes dissociations in
cortical morphometry which affect the cortical capacity for
information processing. Our results demonstrate the morpho-
logical aspects of the functional reorganization in PFC and STG,
and provide structural evidence for their involvement in the
pathophysiology and neurobiology of SAD.
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markers [6], but the results are of limited consistency, in need of vali-
dation and replication [7].
To explore the neuroanatomical substrates of SAD-related patho-
physiology and thus identify potential specific biomarkers of SAD, it
is important to select appropriate structural parameters. To date,
most neuroimaging structural analyses have focused on cortical gray
matter volume (GMV). Several studies investigating SAD have mea-
sured the GMV in cortical and subcortical structures using voxel-
based morphometry (VBM), revealing a widespread but variablepattern of GMV deficits in nearly most cortical and subcortical
regions [8-22]. However, the reported results have been heteroge-
neous and sometimes inconsistent, which may be attributed to a
small sample size, differing patient characteristics (comorbidity with
other psychiatric disorders, concomitant treatment, and sex ratio),
and methodological differences (notably between whole-brain and
hypothesis-driven region of interest (ROI) analyses).
In addition, the cortical volume confounds the effects of both cor-
tical thickness (CT) and cortical surface area (CSA); for example, no
change in GMV could conceal cortical thinning (decreased CT) with
concurrent surface expansion (increased CSA) or vice versa [23].
Therefore, investigating group differences in both CT and CSA may
offer better insights. It is suggested that joint analysis of CT and CSA
should take the place of the analysis of cortical volume [24]. How-
ever, only a handful of original articles have examined CT in SAD
with mixed and partially contradictory results [10,22,2528]. A pilot
ROI-based study involving 13 unmedicated SAD patients found
decreased CT in the frontal pole (rostral prefrontal cortex (PFC)), the
rostral middle frontal gyrus (rMFG) within the dorsolateral PFC
(dlPFC), medial orbitofrontal cortex (mOFC), primary motor cortex,
postcentral gyrus, supramarginal gyrus, temporal pole, inferior tem-
poral gyrus (ITG), fusiform, and insula [25]; in contrast, a subsequent
study including 14 male patients (3 patients with comorbidity and 2
patients with current medication) found only increased CT in the lin-
gual and fusiform gyri [26]; In a recent whole-brain study involving
24 non-comorbid medication-naïve SAD patients, the authors found
abnormalities in brain regions similar to previous reports but often
with opposite alterations [10]; the SAD patients showed increased CT
in the superior frontal gyrus (SFG), caudal MFG, anterior cingulate
cortex (ACC), temporal pole, superior parietal gyrus, supramarginal
cortex, ITG, and insula, and decreased CT in the lateral OFC (lOFC),
rMFG, and precentral cortex. The largest study investigating CT in
SAD assessed 46 patients using both ROI and whole-brain approaches
[27]. In the ROI-based analysis, the SAD patients had larger CT in the
ACC, temporal pole, and insula (only the ACC survived correction for
multiple comparisons); the whole-brain analysis revealed increased
CT in the dlPFC (including the SFG and MFG), right superior parietal
lobule, and angular gyrus. Importantly, 19/46 patients were taking
antidepressant medication, although medication was used as a covar-
iate of no interest to control the effects of treatment in the analysis.
Furthermore, the CSA is a very different morphometry metric
from CT in terms of brain development, cytology, and genetics. Longi-
tudinal studies have revealed the strikingly different developmental
trajectories of CSA and CT [29,30]. An inverse relationship between
CT and CSA (i.e. larger CSA accompanied by thinner cortices or vice
versa) is often reported in both healthy subjects and patients
[29,3133]. This inverse association may be the result of white mat-
ter growth - myelin growth, both subcortical and intracortical, that
stretches the cortex tangentially to the pial surface, like a balloon,
resulting in expanded and thinner cortices - this is the ‘balloon
model’ hypothesis [3436]. At the cellular level, the radial unit
hypothesis suggests that cortical neurons are organized radially as
cell columns and that the CT reflects the number of neurons within
the columns, while the CSA reflects the number of columns [37].
From a genetic perspective, the CSA and CT have been regarded as
essentially unrelated and distinct endophenotypes influenced by dif-
ferent genetic contributions [38]. In practice, while both CT and the
CSA contribute to GMV, a change in the GMV is usually mainly
explained by a change in the CSA [39]. In any case, differences in CT
and CSA should be investigated separately, potentially offering more
neuroanatomical information and better neurobiological insight. So
far only one study has examined the CSA in SAD using an ROI
approach to investigate the co-segregation and heritability of CSA in
families genetically enriched for SAD; in this study, the majority of
subjects (22/39) were diagnosed with subclinical SAD (defined as
meeting the criteria for SAD without impairing limitations in
X. Zhang et al. / EBioMedicine 58 (2020) 102910 3important functioning areas), and most subjects had a psychiatric
comorbidity [28].
In this context, to the best of our knowledge, we conducted the
first whole-brain vertex-wise analysis of structural abnormalities in
both CT and the CSA in non-comorbid never-treated patients with
SAD using FreeSurfer software, a sensitive SBM approach focused on
the cerebral cortex. We also conducted exploratory analyses of the
relationships between the morphological deficits and clinical features
of SAD. In view of existing sparse and mixed SAD-related changes in
CT and CSA, we don’t intend to hypothesize the alteration direction
and pattern of CT/CSA.
2. Materials and methods
2.1. Participants
We recruited thirty-two adult patients with SAD from the outpa-
tient clinic of the Mental Health Center of the West China Hospital,
Sichuan University, Chengdu, China [40]. SAD was diagnosed by con-
sensus of two experienced attending psychiatrists based on the Diag-
nostic and Statistical Manual of Mental Disorders, 4th edition (DSM-
IV) criteria via the Structured Clinical Interview for DSM Disorders
(SCID) [41]. All patients were right-handed and drug-naive without
any comorbid psychiatric disorders.
For comparison, thirty-two HCs matched for sex, age (within a 5-
year gap), and handedness were recruited from the local area
through poster advertisements, and we use the SCID-Non-Patient
Version to confirm the lifetime absence of psychiatric and neurologi-
cal illness. This recruitment plan led to nineteen healthy subjects
having notable levels of social anxiety but not meeting criteria for
SAD.
The exclusion criteria for both patients and HCs included the fol-
lowing: comorbid neurological disorders or other axis I psychiatric
disorders; axis II antisocial or borderline personality disorders (veri-
fied by the SCID); past or current psychiatric treatment (psychophar-
macological or psychological therapy); history of substance
dependence or abuse; learning or developmental disorders; history
of head injury; major physical illness, such as cardiovascular disease,
liver disease or brain tumors, as assessed by clinical evaluations and
medical records; family history of mental disorders; claustrophobia
or other contraindications to magnetic resonance imaging (MRI)
examination; and current pregnancy. Individuals were also excluded
if they were aged under 18 or over 60 years to minimize age-related
effects.
All participants were assessed using the self-administered Liebo-
witz Social Anxiety Scale (LSAS), which is the most commonly used
clinical scale in SAD studies [42]. The LSAS provides a score for both a
fear factor (LSASF) and a social avoidance factor (LSASA), and the total
score (LSAST) is their sum.
All procedures in this study conform to the ethical standards of
the Declaration of Helsinki and the ethical principles in the Belmont
Report. This study was approved by the Medical Research Ethics
Committee of West China Hospital at Sichuan University. All subjects
provided written informed consent before the study.
2.2. MRI data acquisition
We performed whole brain MRI using a 3.0 T MR scanner (Sie-
mens Trio, Erlangen, Germany) with a 12-channel head coil. During
the scans, the subjects were instructed to keep their eyes closed, relax
and remain as still as possible. Foam pads were used to restrict head
motion. We obtained high-resolution three-dimensional T1-
weighted images using a spoiled gradient recalled sequence (repeti-
tion time 1900 ms, echo time 2.26 ms, flip angle 9°, 176 sagittal slice
thickness 1 mm, field of view 240 £ 240 mm2, data matrix
256 £ 256, voxel size 1 £ 1 £ 1 mm3,and in-plane resolution0.94 £ 0.94 mm2). Each scan was inspected by an experienced neuro-
radiologist to rule out visible movement artifacts and gross structural
abnormalities.2.3. Image processing
The cortical reconstruction and estimation of CT and the CSA were
performed based on the 3D-T1 images using the FreeSurfer package
6.0.0 (http://surfer.nmr.mgh.harvard.edu), which consists of a set of
automated sequences to complete the construction of the cortical
model. Briefly, the whole process was completed automatically,
including motion correction, averaging of multiple volumetric T1
weighted images, skull striping using a deformable template model,
automated registration to the Talairach space, segmentation of the
subcortical white matter and deep gray matter volumetric structures,
normalization of intensity, tessellation of the gray matter, and white
matter boundaries, automated topology correction and surface defor-
mation following intensity gradients to optimally place the gray/
white and gray/cerebrospinal fluid borders. The whole segmentation
procedure was visually inspected for inaccuracies, and manual cor-
rections were performed as necessary by adding control points
[43,44]. Subsequently, the procedures involved surface inflation and
registration to a spherical atlas based on individual cortical folding
patterns to match the cortical geometry across the subjects, and then
the cortex was auto-parcellated into 34 different gyral regions per
hemisphere using gyral and sulcal anatomy [45,46]. Eventually, sur-
face maps were created following the registration of the cortical
reconstructions of all subjects to a common average surface, and the
surface maps were smoothed using a Gaussian kernel of 10 mm full-
width half-maximum. CT was defined as the average shortest dis-
tance between the white/gray matter boundary and the gray matter/
CSF boundary at each point [47], and the CSA of each parcellation per
hemisphere was obtained by summing the area of all tessellations on
the gray matter surface [48]. This measurement of the cortical param-
eters using FreeSurfer has been verified against histological analyses
and has good test-retest reliability [44].2.4. Statistical analysis
The group differences in the demographic and clinical data were
assessed using a two-sample t-test for continuous variables (age,
LSAST, LSASA, and LSASF) and chi-square tests for the discrete vari-
able (sex) using IBM SPSS Statistics22.0. Significance level was set at
P < 0.05.
To assess the group differences in CT and the CSA, whole-brain
vertex-wise analyses were performed using the graphical user inter-
face of FreeSurfer known as QDEC (Query, Design, Estimate, Contrast)
[49,50]. We used a general linear model (GLM) to compare the CT
and CSA between the SAD patients and HCs with age and sex as cova-
riates. Because all images were aligned to a common surface tem-
plate, we did not use the intracranial volume as a covariate. The
Monte Carlo Null-Z Simulation was conducted to control for multiple
comparisons (10,000 iterations, cluster-forming P < 0.05, cluster-
wise corrected P < 0.05). Additionally, to control the potential effects
of the anxiety level of HCs, we excluded HCs with LSAS score > 30
and SAD patients with LSAS score  30 [51,52], and conducted a sub-
group analysis (including 30 SAD patients and 13 HCs) to identify CT/
CSA differences between worse-affected SAD patients and
‘completely normal’ subjects (i.e. HCs with low or no symptoms) (see
Supplementary Materials).
To identify the relationships between the structural alterations
and clinical characteristics, the command of mris_anatomical_stats in
FreeSurfer was used to calculate the average CT/CSA in the significant
clusters; then, we conducted a partial correlation analysis between
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of P < 0.05 in the SAD group.
3. Results
3.1. Demographic and clinical characteristics
We enrolled 32 adult patients with SAD and 32 sex- and age-
matched HCs. Table 1 shows their detailed demographic and clinical
characteristics. There were no significant differences between the
groups in the sex composition or mean age. Relative to the HCs, the
subjects with SAD exhibited significantly higher LSAS scores. For sub-
group analysis, LSAS were also higher in SAD patients, and there
were no significant differences in age and sex between the 30 SAD
patients and the 13 HCs (see Table S1).
3.2. Group differences in the CT
The whole-brain vertex-wise analysis revealed that compared to
the HCs, the SAD patients had thinner cortices (lower CT) in three
clusters located in the bilateral SFG with large portions extending
into the rMFG and rostral ACC (corrected with Monte Carlo simula-
tions of P < 0.05). No areas had higher CT in the SAD patients (Fig. 1
and Table 2). All aforementioned results survived well in subgroup
analysis (see Supplementary Materials).
3.3. Group differences in the CSA
The whole-brain vertex-wise analysis revealed that compared to
the HCs, the SAD patients had 5 clusters with significantly larger CSA
as follows: cluster 1 in the left hemisphere mainly covered the SFG
and partially extended into the rostral ACC; cluster 2 in the left hemi-
sphere was located in the rMFG; cluster 3 in the left hemisphere was
mainly located in the STG, extending partly into the middle temporal
gyrus (MTG); cluster 4 in the right hemisphere mainly covered the
SFG and substantially extended into the ACC; and cluster 5 in the
right hemisphere was located in the lOFC extending into the rMFG
(all clusters corrected with Monte Carlo simulations of P < 0.05).
There were no regions with decreased CSA in the SAD patients (Fig. 2
and Table 2). All aforementioned results survived well in subgroup
analysis (see Supplementary Materials).
3.4. Correlation between morphometrical alterations and clinical
variables
After controlling for the confounders of sex and age, the partial
correlation analysis showed that the increased CSA in the left SFG
cluster (in the PFC) was significantly inversely related to the SAD
durations (r = -0.422, P = 0.02) (Fig. 3). There was no significant asso-
ciation between the cortical morphometrical changes and LSAS.able 1
emographics and clinical characteristics of participants.
Characteristics SAD (N = 32) HCs (N = 32) P-value
Sex (Male/Female) 20/12 20/12 1.000*
Age (years) 23.3 § 3.7 (1830) 22.9 § 2.8 (1930) 0.650**
Illness duration (years) 7.3 § 3.5 (115)  
LSAST 62.7 § 22.0 (28103) 39.2 § 23.6 (485) < 0.001**
LSASF 30.9 § 10.4 (1450) 20.1 § 12.5 (247) < 0.001**
LSASA 31.8 § 12.9 (1462) 19.1 § 11.6 (043) < 0.001**
ata are presented as the means § standard deviations (minimum - maximum).
* P value obtained using a chi-square test.
** P value obtained using a two-sample t-test.
bbreviations: HCs, healthy controls; LSAST, LSASF, and LSASA, total score and fear and
voidance factor of the Liebowitz Social Anxiety Scale (LSAS); SAD, social anxiety disorder.4. Discussion
To the best of our knowledge, this study is the first to investigate
cortical morphometrical alterations in both CT and CSA of non-
comorbid never-treated patients with SAD at the whole-brain level.
All patients were non-comorbid and free of treatment, thereby elimi-
nating the confounding effects of comorbidity and therapy, which is
beneficial to explore the “pure” specific SAD-related neurobiological
mechanisms. Compared to the HCs, the patients with SAD had thin-
ner and expanded cortices in the bilateral PFC (mainly bilateral dlPFC,
dorsomedial PFC (dmPFC), ventromedial PFC (vmPFC)), and right
lOFC). In addition, the CSA was increased in the left STG cluster. There
was a negative correlation between the CSA of the left SFG cluster (in
the PFC) and the duration of SAD. These findings were nearly sym-
metrical in the same region of the PFC, the core region of the classic
fear circuit (including the PFC, ACC, insula, amygdala, and hippocam-
pus) that underlies the dysfunctional emotion and cognitive process-
ing in SAD [53]. Our findings may reflect the structural substrate of
the dysfunctional social information processing and emotion regula-
tion in SAD.
4.1. Possible neurobiology of the dissociated morphological alterations
in PFC and cortical expansion in STG
This dissociation of morphological abnormalities (decreased CT
but increased CSA) symmetrically in the bilateral PFC and the cortical
expansion in left STG may reflect a cortical reorganization process. To
explain this type of dissociation, the popular ‘balloon model’ hypoth-
esis proposes that myelin growth, both subcortical and intracortical,
stretches the cortex tangentially to the pial surface, like a balloon,
resulting in expanded and thinner cortices (i.e., larger in surface area
and thinner in thickness) [3436]. Such cortical reorganization has
been suggested to be the result of the differential effects of genes
that control the developmentally distinct periods of symmetric and
asymmetric division and the mechanical effects of gyrification, which
is a process of tangential surface expansion to fit a relatively small
volume [54]. The expansion of a balloon would result in the further
separation of small structural units of the balloon. Likewise, such bal-
loon-like stretching of cerebral cortex could cause the neuronal col-
umns consisting of the structural units to move apart and become
more spatially separated. Meanwhile, the tangential expansion could
also stretch the dendrites in the neuropil between them to a flatter
orientation. These cytoarchitectural alterations lead to less overlap
among neighboring neuronal columns and dendrites; this is expected
to result in greater local functionality in corresponding cortices
including differentiation among afferent information and signal-
processing ability [36], because more tangential arrangements of col-
umns and dendrites could guarantee less interferences from neigh-
boring units and wider columns or modules for sampling a larger set
of incoming signals. In other words, such structural changes of cortex
stretching along with, for example, experience-related pruning and
strengthening of specific connections, disentangles neighboring neu-
ronal columns, enables the relevant parts of the cortex to increase
functional specialization, makes the neuronal units more distinct and
independent regarding functions, and thus more efficient to differen-
tiate incoming signal patterns and potentiate the information-proc-
essing capacity in the cortical regions [35,36].
Such dissociated morphological alterations (larger CSA accompa-
nied by thinner cortices or vice versa) have been observed in studies
of other diseases [5557]. For example, a longitudinal research dem-
onstrated that the relative preservation over time of the CSA and a
thinning of the cortex in the frontal, occipital lobe, and cingulate
observed in a high-risk schizophrenia group may be candidate indica-
tors of vulnerability to schizophrenia [31]. In another study, patients
with Williams syndrome, a rare genetic neurodevelopmental disor-
der characterized by hypersociability (lack of fear for strangers),
Fig. 1. Brain regions with cortical thickness differences between social anxiety disorder patients and healthy controls (corrected with Monte Carlo Null-Z Simulation of P < 0.05).
Warmer colors (positive values) represent increased cortical thickness, while cooler colors (negative values) represent decreased cortical thickness in social anxiety disorder
patients compared to those in healthy controls. Abbreviations: SFG, superior frontal gyrus.
X. Zhang et al. / EBioMedicine 58 (2020) 102910 5which is in some respects the opposite of the symptomatology of
SAD, had a lower CSA with greater CT (i.e., the opposite to our find-
ings) in some cortical regions, such as the SFG, rMFG, and transverse
temporal gyrus [58]. Likewise, reduced CSA predominantly in frontal
and temporal lobes and increased CT mainly in frontal, parietal, and
occipital regions were observed in Down syndrome relative to typical
controls [32]. Intriguingly, a recent study including the ENIGMA-CNV
consortium and the UK Biobank data (45,756 individuals) explored
the associations of pathogenic copy number variations of the 15q11.2
deletion and duplication with cognition and cortical/subcortical mor-
phology. Compared with noncarriers, deletion carriers showed a pat-
tern of decreased CSA and increased CT particularly across the ACC,Table 2
Significant clusters with altered cortical thickness or sur
healthy controls.




Left SFG 9.3 53.1 1
Right SFG 16.3 53.1 1





Left STG 49.3 2.4 
Left SFG 7.6 29.4 3
Left rMFG 39.8 35.6 2
Right lOFC 18.6 20.3 
Right SFG 8.9 51.5 1
SAD < HCs
none
All clusters survived correction for multiple comparisons
rected cluster-wise P< 0.05.
Abbreviations: CWP, cluster-wise probability; HCs, he
rMFG, rostral middle frontal gyrus; SAD, social anxiety d
temporal gyrus.frontal lobe, and pre/postcentral gyrus, while duplication carriers
showed an opposite pattern of increased CSA and decreased CT [33].
Nevertheless, other studies have also reported regions with
altered CT showing no changes in CSA or vice versa [28,59], as well as
CT and CSA changes in the same direction [56,60,61]. Likewise, the
left STG in our study revealed cortical expansion without thickness
changes. Putatively, it is suggested that synaptic pruning and den-
dritic arborization could affect another cortical phenotype, namely
the cortical gyrification, which, along with CSA, is a driving factor of
ontogenetic and phylogenetic changes in GMV [62,63]. Put it another
way, a brain region can increase surface area through complex gyrifi-
cation, with no change in CT, or vice versa [64,65]. Consequently, it isface area in social anxiety disorder patients versus










using a Monte Carlo simulation, resulting in a cor-
althy controls; lOFC, lateral orbitofrontal cortex;
isorder; SFG, superior frontal gyrus; STG, superior
Fig. 2. Brain regions with cortical surface area differences between social anxiety disorder patients and healthy controls (corrected with Monte Carlo Null-Z Simulation of P < 0.05).
Warmer colors (positive values) represent increased cortical surface area, while cooler colors (negative values) represent decreased surface area in social anxiety disorder patients
compared to those in healthy controls. Abbreviations: lOFC, lateral orbitofrontal cortex; rMFG, rostral middle frontal gyrus; SFG, superior frontal gyrus; STG, superior temporal
gyrus.
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might fit well with the currently observed complex relationships of
CT and CSA [66]. Future cytoarchitectonic studies are warranted to
further investigate the sophisticated pattern of cortex.4.2. The dissociated morphological alterations of the PFC in SAD
This finding of significantly reduced CT and increased CSA in the
PFC is consistent with the classic fear circuit model in which dysfunc-
tion in the PFC is involved in the pathogenesis of SAD as it is (along
with the insula, ACC, and amygdala) in other anxiety disorders [53].
As a key node of the classic fear circuit, the PFC potentially plays a
crucial role in social behavior control, information processing, and
emotion regulation [67], and in the latter, different subdivisions of
the PFC perform distinctive functions [68], which we briefly consider
here.Fig. 3. Scatterplots showing negative correlations between average cortical surface area ofThe dlPFC plays a central role in appraisal, reappraisal, subjective
emotion, and self-awareness [69], and its dysfunction may be associ-
ated with increased vulnerability to pathological anxiety [70]. In this
sense, ‘appraisal’ refers to the evaluation of the meaning of the stim-
uli to the organism; ‘reappraisal’, which is an important strategy for
emotion regulation, involves changing the way one thinks about a
situation to decrease its emotional impact and is associated with pos-
itive affect and interpersonal relationships [71]. The idea that dys-
function of the dlPFC may underlie the functional deficiency in
cognitive control including appraisal and reappraisal of emotion reg-
ulation in SAD is supported by a positron emission tomography study
revealing increased blood flow in the dlPFC as SAD patients antici-
pated a public speaking task [72], and the functional MRI evidence of
greater response of dlPFC during regulation for physical threat in SAD
[73]. The adjacent dmPFC is also a hub region for emotional appraisal,
reappraisal, self-referential judgments, and attentional allocation
towards emotional stimuli [74]. The translational circuit of thethe left superior frontal gyrus cluster and disease durations in social anxiety disorder.
X. Zhang et al. / EBioMedicine 58 (2020) 102910 7dmPFC and amygdala has been reported to prompt behaviors to
adapt and circumvent harm when patients with anxiety disorder are
in threatening environments [75]. In addition, the activation of the
dmPFC in anxiety disorder patients has been reported to be nega-
tively related to worry, an internal avoidance strategy that is one of
the core symptoms of SAD, and individuals with anxiety disorder
reappraised less often than HCs and showed less activation in the
dlPFC and dmPFC during reappraisal, which was inversely correlated
with anxiety severity and functional impairments [76]. Considering
the crucial roles of the dlPFC/dmPFC in the appraisal and reappraisal
of emotion regulation, coupled with aforementioned idea that disso-
ciated morphological abnormalities may potentiate the information-
processing capacity, the decreased CT and increased CSA in the
dlPFC/dmPFC observed in the present study may be related to an
undue evaluation of others in social interaction and response to the
sustained reappraisal of anxiety-related stimuli in SAD.
The vmPFC also showed decreased CT and increased CSA in the
SAD patients. Although the vmPFC is also a key node in emotion regu-
lation, it has mainly been implicated in the inhibition and extinction
of fear and anxiety responses [74,77]. In previous neuroimaging stud-
ies, dysfunction in the vmPFC has been related to the generation of
negative emotions, including anxiety and fear [78,79], while SAD
patients demonstrated hyperactivity in (para)limbic regions, includ-
ing the amygdala, insula, and hippocampus, in the face of negative,
especially socially aversive stimuli and participation in socioemo-
tional events [80-82]. Interestingly, greater vmPFC responses to unin-
tentional (embarrassment-mediated) situations were also observed
in SAD patients [83], and regarded as a potential endophenotype of
SAD [84]. It has been speculated that the vmPFC is involved in the
inhibition of fear responses by suppressing overactivity in (para)lim-
bic regions when SAD patients are confronted with anxiety-related
stimuli [68]. Neuroimaging studies have also linked the vmPFC to the
extinction of fear memory as follows: functional MRI demonstrated
increased activity in the vmPFC during extinction recall [85], and
structural MRI showed that the CT in vmPFC was positively correlated
with the magnitude of extinction retention [86]. Hence, the thinner
and expanded cortex of the vmPFC in the present study could be
interpreted as compensatory response of the vmPFC to enhance the
suppression of overactivity in (para)limbic structures and mediate
fear memory extinction in the face of external conditioned stimuli in
SAD. Moreover, our study also observed increased CSA in the right
lOFC. The OFC is involved in various higher-order executive functions,
particularly control and inhibition of incongruous behavioral and
emotional responses, and dysfunction in the OFC has been implicated
in anxiety [87]. Specifically, evidence from neuroimaging studies has
indicated that the lOFC, to some extent like the vmPFC, was dedicated
to mediating responses to negative affective states [88], and hyperac-
tivity in the lOFC was found in the presence of prominent anxiety-
laden cognitions. Accordingly, anxious individuals have been hypoth-
esized to require the enhanced recruitment of the OFC to attenuate
the negative emotional response to aversive stimuli [89]. In support
of this hypothesis, SAD patients have decreased regional cerebral
blood flow in the OFC but increased flow in the amygdala during pub-
lic speaking, which was explained as emotional dysregulation linked
with failure to inhibit negative affect [90]. Thus, the increased CSA in
the lOFC we observed may reflect compensatory mechanisms to
dampen anxiety or a response to the sustained attenuation of nega-
tive emotion in SAD.
Taken together, as noted by Etkin et al. [68], there is an essential
differentiation among PFC subregions. The current findings may pro-
vide a detailed and defined neural structural basis for the different
subdivisions of the PFC involved in the classic fear network and the
hypothesis that the disturbance of the normally well-balanced neuro-
cognitive circuit is related to an imbalance among heightened cogni-
tion (undue appraisal and reappraisal) of anxiety-related stimuli,
overactive emotional arousal to external stimuli, and defective top-down regulatory mechanisms in SAD [91,92], which remains to be
further explored in functional studies.
The exploratory correlation analysis found a negative association
between the increased CSA in the PFC and SAD duration. SAD typi-
cally emerges early in life [93], and is chronic and persistent. Further,
untreated SAD may progressively lead to fear and avoidance of social
situations and relationships. In our sample 22 (69%) patients had
their first onset in adolescence, and the course lasted for many years.
On average, our longer-duration patients showed less increase of CSA
in PFC. According to fear-network theory [53,92], anxiety disorders
are associated with alterations in fear neurocircuitry, such that 'bot-
tom-up' processes in the amygdala which respond to threat are exag-
gerated, and regulation of these processes by PFC is impaired. One
might expect that patients with longer disease course would show
more serious PFC damage, the opposite of our observation of CSA in
PFC. A longitudinal MRI study revealed cortical volume reduction in
bilateral dmPFC in SAD patients after cognitive behavioral group
therapy [22]. Consistent with this, our recent SAD resting study found
an increased resting connectivity in the frontolimbic/perceptual sys-
tem circuits [40]. An appealing interpretation of this finding is that
top-down control modulation is increased but still fails to compen-
sate for heightened social anxiety [40,92]. We suspect that as the dis-
ease progresses, patients gradually reduce such excessive cognitive
efforts. This would make sense of the negative association between
illness duration and CSA PFC. Since clinical population-based devel-
opmental research in the context of brain structure is limited, longi-
tudinal studies will be needed to clarify whether participation of
people with chronic illness will exhibit more or less CSA expansion in
PFC. In addition, our failure to find significant correlations between
symptom severity and neuroanatomical differences is in line with
recent studies [10,27], but somewhat inconsistent with some other
studies that reported significant associations between SAD symptom
severity and structural alterations (in GMV or CT)
[9,11,14,1618,25,26]. This difference may perhaps be explained by
method and sample differences such as sample size and characteris-
tics. Besides, another interpretation proposed by Br€uhl for such lack
of correlation with symptom severity is that those neuroanatomical
alterations were more linked to the category of disorder than the psy-
chopathological dimension [27], which remains to be investigated in
future research.
4.3. The temporal cortical expansion in SAD
Another important finding is the cortical expansion in the left STG
cluster (extending to the MTG). Consistent with our results, a recent
meta-analysis found that non-comorbid SAD patients had larger
GMV in the right STG and MTG [12], while the GMV in the STG
decreased after cognitive behavioral group therapy [94], or after 12
weeks of treatment with escitalopram [95]. Neurofunctionally,
hyperactivation in the STG/MTG has also been observed during facial
emotion processing, emotional response, and a social evaluative
threat task [96]. A recent functional MRI study also revealed a posi-
tive associations between social anxiety level of SAD patients and
brain activation of STG and MTG in response to unintentional social
norm violations [84]. Indeed, the STG is a pivotal component of the
perceptual system involved in the perception of facial expression and
averted gaze, the evaluation of personality traits in others, and analy-
sis of the dispositions and intentions of others’ actions [97]. As
patients with SAD are characterized by excessive focus on others’
intention and facial expression, undue fear of negative appraisal and
scrutiny by others, our findings of temporal expansion may offer
structural evidence for the dysfunctional temporal social information
processing system in SAD [98]. As a crucial region for abstract con-
ceptual social knowledge, STG is active during emotional judgment
of social value-related behavior, across different contexts of moral
sentiments [99]. STG is recruited in conditions that require subjects
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interoceptive information with information about the current envi-
ronmental situation for assessment of emotional state [100]. Addi-
tionally, considering the important roles of those temporal regions in
visual perception and visual mental imagery [101], it is speculated
that increased STG activation may be linked to increased saliency of
the social situations when SAD patients envision themselves in the
hypothetical scenes [84]. It may therefore be that cortical expansion
of STG in our study may reflect structural alterations corresponding
to such functional changes.4.4. Comparison between our results and previous findings and
potential implications
Increasing attention is paid to understanding the pathophysiology
and identifying potential neuroanatomical biomarkers in SAD, but
the results have been of limited consistency. Previous structural MRI
(GMV/CT/CSA) studies, which have been recently summarized in
[28], have reported a wide pattern of brain regions with altered CT,
including the PFC, parietal, and temporal lobule [10,2527]. Several
factors might contribute to the differences from our results. From a
methodological perspective, first, we used automated software Free-
Surfer for preprocessing and statistical analysis; this is a validated
SBM method with good test-retest reliability which has been verified
against histological analyses [44,102]. In contrast some previous
studies used manual segmentation or less accurate software
[103,104]. Second, we used vertex-wise whole brain comparison, dif-
ferent from the ROI analysis adopted in some other studies [25,27],
which increases the risk of Type II error dramatically [105]. Third,
GMV is a complicated parameter, driven by many factors such as CT,
CSA, and cortical folding (gyrification) [24], so group differences in
GMV may be not necessarily explained by those in CT or CSA; a clus-
ter with altered GMV may show no differences in CT or CSA [39].
Fourth, VBM and SBM differ in terms of methodology and biology,
and SBM is more sensitive to abnormalities of gray matter structure
in some circumstances, and differences in results from two methods
have been reported [106,107]. Turning now to sampling, medications
and comorbidity can confound results. Our SAD patients are non-
comorbid never-treated, while previous studies recruited comorbid
and/or treated patients; studies have shown that comorbidity with
other psychiatric disorders and therapy have effects on gray matter
structures [22,108]. For instance, patients with MDD comorbid with
generalized anxiety disorder show thinner cortices in the right fusi-
form gyrus and medial orbitofrontal area, and left temporal pole and
lateral occipital lobe, compared with HCs and non-comorbid MDD
patients [109]. Another potential confounder is that some of our HCs
showed some levels of anxiety falling short of DSM-IV criteria for
SAD: we consider this in the Limitations section. In short, there are
many aspects of the methodological, medical, and socio-demographic
domains that are associated with, or perhaps cause, neuroanatomical
abnormalities in SAD.
Additionally, comorbid disorders are highly prevalent and signifi-
cantly affect the clinical course in patients with SAD. Co-occurring
and overlapping symptoms may lead to complicated clinical presen-
tation, and increase the risk of misdiagnosis and poorer treatment
outcomes [110]. In vivo neuroimaging allows the investigation of
brain changes associated with anxiety disorders. However, mapping
complex symptoms onto similarly complex multivariate brain pat-
terns in heterogeneous samples could confound results. Thus, SAD
patients with comorbidity may have different underlying clinical and
neural mechanisms from patients without comorbidity. To minimize
the possibility that analytic results are driven by comorbidity, we lim-
ited the inclusion criteria to a particular non-comorbid group of par-
ticipants. For similar reasons, patients with comorbidities have often
been excluded from treatment studies in SAD [111]. The applicationof the strict inclusion criteria in the current study in effect increases
the internal validity at some cost to the external validity.
Furthermore, neuroscience has an important role in a transla-
tional approach to inform not only the selection, optimal use, refine-
ment or development of treatment strategies but also the non-
pharmacological neurobiological interventions. For instance, the
choice of deep brain stimulation of the subgenual cingulate as
described by Mayberg and colleagues was based on converging evi-
dence from neuroimaging studies which linked this region to sadness
in healthy volunteers [112]. As a result, those regions with gray mat-
ter abnormalities are potential therapy targets. For example, direct
modulation of anxiety-related regions via real-time functional MRI
neurofeedback [113], repetitive transcranial magnetic stimulation
[114,115], deep brain stimulation [112], and drug targeted to those
regions may be promising strategies. Additionally, if future studies
confirm the close (perhaps causal) relation between the gray matter
alterations and occurrence and progression of SAD, those regions
could be neurobiological biomarkers for early diagnosis of SAD, and
noninvasive and reliable tools for therapeutic efficacy evaluation and
disease prognosis [116]. As Bas-Hoogendam pointed out in a recent
review, insight into the neurobiology of SAD is essential for conduct-
ing effective interventions to improve the life quality of SAD patients
[7]. Despite many important efforts, there are still significant gaps
between neuroscience and clinical practice. Current symptom-based
diagnostic categories for psychiatric disorders are not defined by
pathophysiology, and what remains largely obscure is the association
between pathophysiological mechanisms and clinical symptoms. Fur-
ther, a better understanding is needed of anxiety-based measures in
longitudinal studies of treatment effect.
4.5. Limitations
First, a cross-sectional study cannot definitively identify causal
relationships between structural alterations and disease state. To do
this we will need large longitudinal studies recruiting high-risk peo-
ple (such as people with high innate vulnerability of developing SAD
based on the genotypes and endophenotypes [117,118]) and follow-
ing-up SAD patients long-term. Second, it would have been desirable
to measure and if feasible to match the patients with HCs in intelli-
gence, as a previous meta-analysis has shown that brain volume is
positively correlated with intelligence [119]. However, as there is no
clear evidence that SAD patients suffer from intellectual impairment,
we do not expect that this is a significant confounder. Third, our sam-
ple size is not large compared to recent studies investigating other
psychiatric disorders, as we used strict inclusion criteria of non-
comorbid never-treated adult SAD patients, with the hope to explore
the “pure” SAD-specific pathophysiology and neurobiology; to the
best of our knowledge, the current study is thus far the largest study
investigating thickness and surface area in non-comorbid never-
treated SAD patients at the whole-brain level; however, the strict cri-
teria may also limit the generalizability of our findings, so future
studies may benefit from investigating the effects of those con-
founded factors on the cortical morphological alterations. Fourth, we
used a SBM analysis to determine CT and the CSA in the cortical man-
tle and therefore likely missed relevant changes in subcortical struc-
tures, such as the amygdala, thalamus, striatum, and hippocampus,
which are of vital importance in the pathogenesis of SAD [92]. Fifth,
the diagnosis and absence of SAD was confirmed by two experienced
psychiatrists based on the DSM-IV, while LSAS scores were not
applied to restrict the recruitment of patients and HCs. Indeed, our
recruitment plan led to some healthy subjects having notable levels
of social anxiety but not meeting criteria for SAD. Nevertheless, the
subgroup analysis between SAD patients (LSAS score > 30) and
“completely normal” (LSAS score  30) indicated that our main
results survived well and the effects of notable anxiety level in HCs
on our findings were limited. In the future studies, the LSAS scores
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could be conducted to investigated the differences among SAD
patients, healthy people with notable anxiety levels, and traditionally
“completely normal” healthy subjects.
5. Conclusion
In summary, this study is the first to identify the dissociations in
cortical morphometry including the CT and the CSA in non-comorbid
never-treated adult patients with SAD at the whole-brain level,
which complemented and extended prior SAD-related neuroimaging
studies. Our findings of dissociated morphological alterations in the
bilateral PFC and cortical expansion in the left STG may provide a
detailed and solid structural evidence for the involvement of different
subdivisions of the PFC and STG in dysfunctional emotion processing
and regulation, as well as the inhibition and memory extinction of
the excessive fear and anxiety responses in SAD, which might offer
some preliminary information for understanding of the neurobiologi-
cal basis of SAD and further identification of candidate biomarkers in
SAD.
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